首页> 美国政府科技报告 >Use of Liposomes for Directed Drug Delivery against Entamoeba Histolytica
【24h】

Use of Liposomes for Directed Drug Delivery against Entamoeba Histolytica

机译:脂质体用于针对阿米巴(Entamoeba Histolytica)定向给药的用途

获取原文

摘要

The overall goal of this research has been to determine the feasibility anddevelop conditions for use of recognition specific liposomes as a means for targeted drug delivery against the intestinal parasite, Entamoeba histolytica. The specific research objectives were to: identify lipid molecules of mammalian target cell membranes that stimulate phagocytosis by E. histolytica; construct chemically defined liposomes that are selectively phagocytized by the parasite; determine the ability of specific liposomes to deliver drugs and kill E. histolytica trophozoites in culture and protect cultured mammalian cells from destruction by the parasite; develop an animal model and use this to test the ability of drug loaded liposomes to eliminate the parasite in situ. Significant progress has been made on all but the last of three objectives. Two manuscripts of this work have been published and a third is in preparation. The results of this research is summarized below. The ability of purified glycosphingolipids to enhance liposome stimulated Entamoeba histolytica actin polymerization was assessed as a means to define the specificity of mammalian cell membrane lipid glycan recognition by this parasite. Synthetic liposomes containing a variety of individual glycosphingolipids bearing neutral, straight chain oligomeric glycans with galactose or N-acetylgalactosamine termini stimulated rapid (90 sec) polarization of amoeba actin. Glycans with terminal N-acetylglucosamine residues were not, or only weakly, stimulatory. Glycans with glucose, N-acetylglucosamine, galactose and N-acetylgalactosamine as the penultimate residue were recognized.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号